Mylan Labs Gets Nod To Manufacture Remdesivir For COVID-19 Patients
India News | ANI | Friday July 3, 2020
The Drug Controller General of India (DCGI) has granted permission to Mylan laboratories to manufacture and market the anti-viral drug remdesivir for ''restricted emergency use'' on hospitalised COVID-19 patients, a senior government official said on Thursday.
Foreign Investment Board Clears Mylan's Rs 4,960 Crore FDI Proposal
Business | Press Trust of India | Friday August 14, 2015
Based on the recommendations of FIPB meeting held on July 13, 2015, Mylan Laboratories Ltd's proposal for Rs 4,960 crore FDI has been recommended for approval of CCEA, a Finance Ministry statement said.
Government Clears FDI Proposals Worth Rs 10,379 Crore
Business | Press Trust of India | Friday August 14, 2015
The investment proposals were approved following the recommendation for the same by the Foreign Investment Promotion Board (FIPB), headed by Finance Secretary Rajiv Mehrishi.
Mylan to Acquire Famy Care's Women's Health Business for $800 Million
Business | Monday February 2, 2015
Mylan Inc will acquire certain businesses of Mumbai-based Famy Care Ltd, a specialty women's health care company, for a total consideration of $800 million (over Rs 4,940 crore).
US-Based Gilead Licenses Hepatitis C Drug to Cipla, Ranbaxy, 5 Others
Business | Monday September 15, 2014
US drug maker Gilead Sciences Inc on Monday said it has licensed its hepatitis C drug to seven companies including Cipla Ltd and Ranbaxy Laboratories Ltd to make it available in 91 developing countries including India.
Mylan's Rs 5,168 crore deal to buy Strides unit gets cabinet nod
Business | Tuesday September 3, 2013
The acquisition, however, is subject to certain conditions. After the completion of the acquisition process, Mylan has to maintain the investment level in R&D in value terms for five years at absolute quantitative level at the time of induction of FDI, according to sources.
Government clears 17 FDI proposals worth Rs 262 crore
Business | Wednesday May 8, 2013
The government said on Tuesday that it has cleared 17 foreign direct investment proposals totaling Rs 262.56 crore, including that of Sanofi-Synthelabo (India).
Government approves 12 FDI proposals worth over Rs 802 crore
Business | Wednesday March 6, 2013
Government today said it has approved 12 foreign direct investment (FDI) proposals, including that of Ratnakar Bank, totaling over Rs 802 crore.
Mylan Labs Gets Nod To Manufacture Remdesivir For COVID-19 Patients
India News | ANI | Friday July 3, 2020
The Drug Controller General of India (DCGI) has granted permission to Mylan laboratories to manufacture and market the anti-viral drug remdesivir for ''restricted emergency use'' on hospitalised COVID-19 patients, a senior government official said on Thursday.
Foreign Investment Board Clears Mylan's Rs 4,960 Crore FDI Proposal
Business | Press Trust of India | Friday August 14, 2015
Based on the recommendations of FIPB meeting held on July 13, 2015, Mylan Laboratories Ltd's proposal for Rs 4,960 crore FDI has been recommended for approval of CCEA, a Finance Ministry statement said.
Government Clears FDI Proposals Worth Rs 10,379 Crore
Business | Press Trust of India | Friday August 14, 2015
The investment proposals were approved following the recommendation for the same by the Foreign Investment Promotion Board (FIPB), headed by Finance Secretary Rajiv Mehrishi.
Mylan to Acquire Famy Care's Women's Health Business for $800 Million
Business | Monday February 2, 2015
Mylan Inc will acquire certain businesses of Mumbai-based Famy Care Ltd, a specialty women's health care company, for a total consideration of $800 million (over Rs 4,940 crore).
US-Based Gilead Licenses Hepatitis C Drug to Cipla, Ranbaxy, 5 Others
Business | Monday September 15, 2014
US drug maker Gilead Sciences Inc on Monday said it has licensed its hepatitis C drug to seven companies including Cipla Ltd and Ranbaxy Laboratories Ltd to make it available in 91 developing countries including India.
Mylan's Rs 5,168 crore deal to buy Strides unit gets cabinet nod
Business | Tuesday September 3, 2013
The acquisition, however, is subject to certain conditions. After the completion of the acquisition process, Mylan has to maintain the investment level in R&D in value terms for five years at absolute quantitative level at the time of induction of FDI, according to sources.
Government clears 17 FDI proposals worth Rs 262 crore
Business | Wednesday May 8, 2013
The government said on Tuesday that it has cleared 17 foreign direct investment proposals totaling Rs 262.56 crore, including that of Sanofi-Synthelabo (India).
Government approves 12 FDI proposals worth over Rs 802 crore
Business | Wednesday March 6, 2013
Government today said it has approved 12 foreign direct investment (FDI) proposals, including that of Ratnakar Bank, totaling over Rs 802 crore.
................................ Advertisement ................................
................................ Advertisement ................................
